List of SBIR/STTR awards granted to Orlance, Inc.
Orlance, Inc.Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to Orlance, Inc. in May, 2019 for $1,000,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 7R44AI122371-03 | Phase II | 1,000,000 | May 1, 2019 | |||||||
A SBIR Phase I contract was awarded to Orlance, Inc. in April, 2018 for $598,613.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI140784-01 | Phase I | 598,613 | April 11, 2018 | |||||||
A SBIR Phase I contract was awarded to Orlance, Inc. in August, 2020 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44AI153011-01A1 | Phase I | 300,000 | August 7, 2020 | |||||||
A SBIR Phase II contract was awarded to Orlance, Inc. in September, 2018 for $1,562,666.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 7R44AI114331-03 | Phase II | 1,562,666 | September 1, 2018 | |||||||
A SBIR Phase II contract was awarded to Orlance, Inc. in May, 2022 for $1,000,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44AI153011-02 | Phase II | 1,000,000 | May 3, 2022 | |||||||
A SBIR Phase II contract was awarded to Orlance, Inc. in May, 2019 for $2,908,934.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44AI122371-02A1 | Phase II | 2,908,934 | May 1, 2019 | |||||||
A SBIR Phase II contract was awarded to Orlance, Inc. in September, 2023 for $996,500.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44AI179440-01 | Phase II | 996,500 | September 1, 2023 | |||||||
A SBIR Phase I contract was awarded to Orlance, Inc. in September, 2023 for $200,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43CA281585-01A1 | Phase I | 200,000 | September 21, 2023 |
